AME6:F:F-Amundi Index Solutions - Amundi Stoxx Europe 600 (EUR)

ETF | Others |

Last Closing

USD 137.26

Change

0.00 (0.00)%

Market Cap

USD 0.71B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.38 (+0.74%)

USD 128.40B
SXR8:F iShares Core S&P 500 UCITS ETF..

+5.34 (+0.97%)

USD 114.04B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.32 (+0.56%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.10 (+0.68%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 53.72B
SXRZ:F iShares VII PLC - iShares Nikk..

+1.55 (+0.68%)

USD 52.44B
VUSA:F Vanguard Funds Public Limited ..

+0.22 (+0.22%)

USD 51.63B
0ZC:F Zscaler Inc

-0.95 (-0.43%)

USD 37.92B
BSND:F Danone SA

N/A

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

+0.46 (+0.36%)

USD 24.77B

ETFs Containing AME6:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.05% 80% B- 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.05% 80% B- 72% C
Trailing 12 Months  
Capital Gain 8.25% 73% C 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.25% 71% C- 59% D-
Trailing 5 Years  
Capital Gain 82.77% 74% C 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 82.77% 75% C 54% F
Average Annual (5 Year Horizon)  
Capital Gain 10.79% 74% C 68% D+
Dividend Return 10.79% 71% C- 59% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.52% 57% F 88% B+
Risk Adjusted Return 93.66% 87% B+ 91% A-
Market Capitalization 0.71B 66% D+ 52% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike